Zarema’s practice focuses on complex antitrust matters including mergers & acquisitions, joint venture transactions, and high-stakes class action litigation dealing with price fixing and monopolization issues. Zarema represents clients before the U.S. Federal Trade Commission, the U.S. Department of Justice, and foreign competition agencies. She also counsels clients contemplating complex transactions that may be affected by antitrust statutes including Hart-Scott-Rodino.

She represents clients in many sectors including financial services, pharmaceutical, high technology, and telecommunications. Her work in the pharmaceutical sector includes high-profile investigations and litigation involving “pay for delay” deals. She also advises clients in major criminal and civil cases and governmental investigations involving alleged fraud under the Foreign Corrupt Practices Act. Her work with financial institutions and their executives centers on securities class actions, shareholder derivative claims, and investigations by the U.S. Securities and Exchange Commission.

Zarema’s clients benefit from her extensive experience in and understanding of the U.S. government. She served as a trade specialist for the U.S. Department of Commerce’s International Trade Administration in the Office of China and as the Program Manager of the U.S. Department of Commerce Corporate Governance Program in the Office of Russia. During her tenure in these roles, she provided guidance to U.S. companies regarding U.S., Russian, Chinese, and multilateral treatises; regulations; and dispute-resolution mechanisms. To help them comply with international standards, she designed and implemented training programs for business and legal practitioners in Russia and Central Asia that addressed corporate governance, intellectual property rights protection, and commercial dispute resolution.

Zarema is fluent in Russian and proficient in French.